« Copyright Law by V. Hart |
| Pandora is Not Happy at David Lowery »
July 8, 2013
POST A COMMENT
What Protects Medicine Sales, If Not Patents?
The team at NPR's Planet Money took a look at this question for standard headache remedies (asprin, etc) that are long out of patent protection and found that even though cheap generic versions are often shelved side-by-side with the more expensive brand-name versions, brand names still thrive. These are drugs that are long past, or never had, patent protection, so the question of why sales of non-generics still thrive. The answer isn't easy to figure - it has something to do with convenience, something to do with image, and something to do with lack of information. What it does highlight, though, is that monopolistic practices aren't the only route to success in a competitive marketplace.
posted by Alan Wexelblat |
- RELATED ENTRIES
- CBS to HBO: Wait for Us!
- Sometime Next Year, HBO Will Become Netflix
- OpenMedia vs the TPP
- CopyrightX 2015 (online course) Now Open
- College Students vs Rising Textbook Prices
- "Amazon is crowdsourcing their slush pile"
- Rule 84 and Patent Trolls
- Sports Continue to Tiptoe Away from Cable Monopolies